HIGHLIGHTS
- who: Xueqian Shang from the Nanjing Medical University, China have published the research work: Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma, in the Journal: (JOURNAL)
- what: The study provides a robust model and candidate biomarkers for personalized therapy of LUAD patients.
SUMMARY
Gene expression profiles from the GEO database were processed according to the following: when a gene was mapped to more than one probe, the gene_expression was considered the median. Immune cell infiltration in bulk tumor gene_expression data To . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.